Physician profile
Steven Schmidt
NPI 1306860002
$1,854.37
in general payments reported to CMS, 2019-2025
19 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $80.11 · 2021: $297 · 2022: $113 · 2023: $214 · 2024: $585 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $834 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $834.18 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $594.50 | 2024-2025 | Integra, Durasorb Monofilament Mesh, Integra Dermal Regeneration Template |
| Mentor Worldwide LLC | $501.81 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Davol INC. | $161.71 | 2019-2021 | |
| Allergan, INC. | $107.60 | 2019-2021 | |
| Musculoskeletal Transplant Foundation INC. | $92.25 | 2024-2025 | |
| Becton, Dickinson and Company | $67.98 | 2019-2025 | Phasix Mesh |
| Sientra, INC. | $64.94 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $39.06 | 2019-2023 | Exparel |
| Paratek Pharmaceuticals, INC. | $30.10 | 2021-2022 | |
| Heron Therapeutics, INC. | $28.75 | 2022 | |
| Axogen | $28.60 | 2022-2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Kci USA, INC. | $26.76 | 2023 | Prevena Restor Bellaform, Spoton, V.A.C. Veraflo Cleanse Choice |
| Abbvie INC. | $23.89 | 2023 | Botox |
| Novartis Pharmaceuticals Corporation | $19.22 | 2022 | |
| Merz North America, INC. | $18.64 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $17.83 | 2019 | |
| Avanos Medical | $16.26 | 2025 | On-Q Pump and Accessories |
| Elutia, INC. | $14.47 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.